Pharmaxis Investor Briefing - Clinical Trial Results | 12 July 2023

12th Jul 23

Release Date: 12/07/2023 12:00am

Pharmaxis Ltd (ASX: PXS) heldĀ an online investor briefing by chief executive officer Mr Gary Phillips on July 12 2023.

The event consistedĀ of a short presentation on the final interim analysis of data from patients from the PXS-5505 Phase 2 cancer trial, followed by a Q&A session from attendees.

View the presentation slides here

Categories: Video Content